HOME About Santen News Investor Relations Products Careers  
 

The 93rd Annual General Meeting of Shareholders

About the Annual General Meeting 2005


Santen Pharmaceutical Co., Ltd. held its 93rd Annual General Meeting of Shareholders on June 24, 2005. The Meeting started at 10:00 a.m. and ended at 10:47 a.m. The number of shareholders attended was 111.


Matters reported:
1. Business Report, Consolidated Balance Sheet, Consolidated Income Statement, Non-Consolidated Balance Sheet and Non-Consolidated Income Statement for the 93rd Business Term (April 1, 2004 to March 31, 2005)
2. Independent Auditor’s Report and Corporate Auditors’ Report on the consolidated financial statements
3. Report on the buy-back of Company stock pursuant to the resolution of the Board of Directors as authorized by the Articles of Incorporation


Matters resolved:
Six items of business as described below were resolved.

Resolution [PDF:41KB]


Questions:
A shareholder submitted a question on the proposed increase in the number of Board members.


Back to top
 
Research & Development
Share Price
20-minute delayed share price and charts.

Provided by MONEX, Inc.
Download Adobe® Reader® to view PDF files.
  Get Adobe Reader